Of the 264
published studies, more than 70% found an association with a risk of
cancer, some higher and some lower. When meta-analyses were published,
though, the results (increased or decreased) were more conservative.
That’s cause the outliers are more likely to get published.
offers promise the less-invasive procedure may one day serve as a
staging tool for the most common gynecological malignancy -- as it does
now for other cancers -- with fewer associated risks and complications
For GPs on the
frontline, decision-making about PSA testing is extremely difficult and
complex. Understanding GPs’ reasoning in this way helps to explain why
different GPs are making different testing decisions in similar cases.
of the classification, the risk of relapse and the prediction of
response to multidisciplinary treatment for early breast cancer has been
the major theme of the 14th St Gallen International Breast Cancer
Consensus Conference 2015.
the mice that received the triple-combination therapy (MEK inhibitor
trametinib + BRAF inhibitor dabrafenib + immunotherapy, either anti-PD1
antibody or tumor antigen-specific adoptive cell transfer) lived at
least twice as long as those that received the double-combination
study published in the Proceedings of the National Academy of Sciences
last year showed that entinostat might boost the effectiveness of two
types of checkpoint drugs—PD-1 and CTLA-4 blockers, which help the
immune system recognize tumors.
The Phase 1b/2
study will evaluate this novel combination regimen in patients with
either advanced non-small cell lung cancer (NSCLC) or melanoma. The
study is expected to begin enrolling patients in the second half of
medicines regulators are asking for feedback on a newly released plan
intended to lay out the European Medicines Agency (EMA) and the Heads of
Medicines Agencies’ (HMA) strategic direction for the next five years.
specialist Prof. Axel Grothey from the Mayo Clinic in Rochester, USA,
said: “ ESMO Clinical Practice Guidelines on Rectal Cancer, and on other
cancers, are popular internationally even outside Europe. This is
because physicians in practice need guidance and ESMO’s guidelines are
much more practice oriented than many other guidelines.”
In a farewell
town hall meeting March 24, NCI Director Harold Varmus reflected on
statements he made during his first day on the job, July 12, 2010,
summarizing the proceeding four-and-three-quarter years; listing goals
met and lamenting work left unfinished.
If there’s one
claim that irritates me that various proponents of alternative medicine
like to make, it’s that cancer is a “modern” disease, that it was rare
(or even didn’t exist) before the rise of modern societies, particularly
the industrial revolution.
indicates that Western blots were cropped badly, which omitted several
panels discussed in the text, while an “extra time point” was included
accidentally. An antibody was also omitted from the description of the
Some of the
most advanced medical centers are starting to make medical information
more available to patients. Brigham and Women’s, where Mr. Keating had
his surgery, is part of the Partners HealthCare Group, which now has
500,000 patients with web access to some of the information in their
health records including conditions, medications and test results.
chose neither a happy or sad ending to represent progress in pediatric
cancer treatment. Rather, it engages the audience with one true story
that leads to a good outcome and another that leads to death. The viewer
can’t anticipate which child will live.
PBS’ “Cancer: The Emperor of All Maladies” is exactly the documentary
one wishes every person who has ever been captivated by a breathless
news report about cancer research would watch first.